WuXi Biologics (Cayman) Inc.
WXXWY
#1138
Rank
$20.244 B
Marketcap
China
Country
$9.86
Share price
-0.30%
Change (1 day)
23.04%
Change (1 year)
Categories
WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from…
Key Metrics
Trailing P/E
30.12
Forward P/E
—
EPS (TTM)
$0.34
Forward EPS
—
Price / Book
3.02
EV / EBITDA
1.7x
Beta
0.60
Dividend Yield
—
Return on Equity
11.64%
Return on Assets
6.88%
Debt / Equity
5.85
Current Ratio
3.39
Gross Margin
45.98%
Operating Margin
33.14%
Net Profit Margin
22.53%
Free Cash Flow
$4.284B
Charts
Price history and financial performance over time.
Price & Market Cap
Jul 6 – Aug 4
+6.44%
Source: Yahoo Finance daily closes. Market cap uses the closest quarterly shares-outstanding filing for each date.
Revenue & Net Income
Annual · USD
RevenueNet Income
Latest Revenue$3.209B
Latest Net Income$722.910M
Reporting periods4
Source: Yahoo Finance annual income statements. Year is the fiscal-year end. Most recent period may be trailing-twelve-month (TTM) until the next 10-K is filed.
Compare WuXi Biologics (Cayman) Inc. with competitors
Side-by-side market cap, revenue, and financial comparison.
Latest News
Latest News
WXXWY
No recent news available. Set FINNHUB_API_KEY to enable news.
